原发性硬化性胆管炎
双盲
医学
随机对照试验
内科学
胃肠病学
病理
替代医学
疾病
安慰剂
作者
Woo Hyun Paik,Joo Kyung Park,Moon Jae Chung,Gunn Huh,C.H. Park,Sang Hyub Lee,Heon Se Jeong,Han Jo Kim,Do Hyun Park
标识
DOI:10.3350/cmh.2024.0629
摘要
A clinical unmet need persists for medications capable of modulating the progression of primary sclerosing cholangitis (PSC). This study aimed to assess the clinical feasibility of HK-660S (beta-lapachone) in PSC.
科研通智能强力驱动
Strongly Powered by AbleSci AI